US Edition
Published • loading... • Updated
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
About three million Canadian adults use GLP-1 drugs, with over half reporting reduced appetite; many reduce dining out and increase spending on fresh foods and wellness items.
- A poll released Monday found about two million Canadian adults are not taking GLP-1 drugs but would like to, based on 1,536 respondents from Feb. 6 to 9, 2026.
- Leger Healthcare's poll shows about three million Canadian adults use GLP-1 drugs; main reasons include weight loss, with 58% citing it, and barriers like cost and coverage. Respondents also said side-effect risks influence their interest.
- Leger reports GLP-1 users are changing shopping habits, with more spending on clothes, personal care, beauty services, and buying more fruits, vegetables, and protein, while eating out less.
- About two million Canadian adults want access, with a quarter paying fully out of pocket and only 28 per cent having full insurance coverage.
- Leger Healthcare said 'GLP-1s are no longer a niche health topic' and noted a hypothetical ±2.5% margin for online surveys, which can't be assigned a true margin of error.
Insights by Ground AI
38 Articles
38 Articles
The Toronto Star+31 Reposted by 31 other sources
3M Canadian adults taking GLP-1 drugs, reshaping eating and spending, survey suggests
TORONTO - A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost
·Toronto, Canada
Read Full Article
Coverage Details
Total News Sources38
Leaning Left22Leaning Right1Center6Last UpdatedBias Distribution76% Left
Bias Distribution
- 76% of the sources lean Left
76% Left
L 76%
C 21%
Factuality
To view factuality data please Upgrade to Premium
